DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation

Atrial fibrillation (AF) and coronary artery disease requiring percutaneous coronary intervention (PCI) and stenting often coexist in older patients. This poses the difficult problem of concurrent anticoagulant and double antiplatelet therapy (triple therapy). Current treatment guidelines do recomme...

Full description

Bibliographic Details
Main Authors: Mauro Di Bari, Alessandra Pratesi, Francesca M. Nigro, Irene Marozzi, Stefano Fumagalli
Format: Article
Language:English
Published: PAGEPress Publications 2018-06-01
Series:Monaldi Archives for Chest Disease
Subjects:
Online Access:https://www.monaldi-archives.org/index.php/macd/article/view/957
_version_ 1811275984621535232
author Mauro Di Bari
Alessandra Pratesi
Francesca M. Nigro
Irene Marozzi
Stefano Fumagalli
author_facet Mauro Di Bari
Alessandra Pratesi
Francesca M. Nigro
Irene Marozzi
Stefano Fumagalli
author_sort Mauro Di Bari
collection DOAJ
description Atrial fibrillation (AF) and coronary artery disease requiring percutaneous coronary intervention (PCI) and stenting often coexist in older patients. This poses the difficult problem of concurrent anticoagulant and double antiplatelet therapy (triple therapy). Current treatment guidelines do recommend triple therapy, especially in the course of acute coronary syndrome (ACS), with limitations due to an excessive risk of bleeding associated with this therapeutic regimen. This review summarizes randomized clinical trials and observational studies that compared triple therapy with a variety of different therapeutic options. Although the available evidence is not completely satisfactory and other studies are urgently needed, alternative regimens to triple therapy in AF patients undergoing PCI and stenting are promising, at least in terms of safety.
first_indexed 2024-04-12T23:47:18Z
format Article
id doaj.art-a41a006fe8664a49aa0e7742279ca8ba
institution Directory Open Access Journal
issn 1122-0643
2532-5264
language English
last_indexed 2024-04-12T23:47:18Z
publishDate 2018-06-01
publisher PAGEPress Publications
record_format Article
series Monaldi Archives for Chest Disease
spelling doaj.art-a41a006fe8664a49aa0e7742279ca8ba2022-12-22T03:11:49ZengPAGEPress PublicationsMonaldi Archives for Chest Disease1122-06432532-52642018-06-0188210.4081/monaldi.2018.957DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillationMauro Di Bari0Alessandra Pratesi1Francesca M. Nigro2Irene Marozzi3Stefano Fumagalli4University of Florence, Department of Experimental and Clinical MedicineUniversity of Florence, Department of Experimental and Clinical MedicineUniversity of Florence, Department of Experimental and Clinical MedicineUniversity of Florence, Department of Experimental and Clinical MedicineUniversity of Florence, Department of Experimental and Clinical MedicineAtrial fibrillation (AF) and coronary artery disease requiring percutaneous coronary intervention (PCI) and stenting often coexist in older patients. This poses the difficult problem of concurrent anticoagulant and double antiplatelet therapy (triple therapy). Current treatment guidelines do recommend triple therapy, especially in the course of acute coronary syndrome (ACS), with limitations due to an excessive risk of bleeding associated with this therapeutic regimen. This review summarizes randomized clinical trials and observational studies that compared triple therapy with a variety of different therapeutic options. Although the available evidence is not completely satisfactory and other studies are urgently needed, alternative regimens to triple therapy in AF patients undergoing PCI and stenting are promising, at least in terms of safety.https://www.monaldi-archives.org/index.php/macd/article/view/957Dual anti-platelet therapytriple therapyacute coronary syndromeatrial fibrillationolder patientshemorrhagic vs thromboembolic risk.
spellingShingle Mauro Di Bari
Alessandra Pratesi
Francesca M. Nigro
Irene Marozzi
Stefano Fumagalli
DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation
Monaldi Archives for Chest Disease
Dual anti-platelet therapy
triple therapy
acute coronary syndrome
atrial fibrillation
older patients
hemorrhagic vs thromboembolic risk.
title DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation
title_full DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation
title_fullStr DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation
title_full_unstemmed DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation
title_short DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation
title_sort dapt plus anticoagulant therapy the difficult coexistence post acs in older patients with atrial fibrillation
topic Dual anti-platelet therapy
triple therapy
acute coronary syndrome
atrial fibrillation
older patients
hemorrhagic vs thromboembolic risk.
url https://www.monaldi-archives.org/index.php/macd/article/view/957
work_keys_str_mv AT maurodibari daptplusanticoagulanttherapythedifficultcoexistencepostacsinolderpatientswithatrialfibrillation
AT alessandrapratesi daptplusanticoagulanttherapythedifficultcoexistencepostacsinolderpatientswithatrialfibrillation
AT francescamnigro daptplusanticoagulanttherapythedifficultcoexistencepostacsinolderpatientswithatrialfibrillation
AT irenemarozzi daptplusanticoagulanttherapythedifficultcoexistencepostacsinolderpatientswithatrialfibrillation
AT stefanofumagalli daptplusanticoagulanttherapythedifficultcoexistencepostacsinolderpatientswithatrialfibrillation